...
首页> 外文期刊>The New England journal of medicine >Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
【24h】

Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.

机译:生理起搏与心室起搏对心血管原因引起的中风和死亡风险的影响。加拿大生理起搏研究者试验。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Evidence suggests that physiologic pacing (dual-chamber or atrial) may be superior to single-chamber (ventricular) pacing because it is associated with lower risks of atrial fibrillation, stroke, and death. These benefits have not been evaluated in a large, randomized, controlled trial. METHODS: At 32 Canadian centers, patients without chronic atrial fibrillation who were scheduled for a first implantation of a pacemaker to treat symptomatic bradycardia were eligible for enrollment. We randomly assigned patients to receive either a ventricular pacemaker or a physiologic pacemaker and followed them for an average of three years. The primary outcome was stroke or death due to cardiovascular causes. Secondary outcomes were death from any cause, atrial fibrillation, and hospitalization for heart failure. RESULTS: A total of 1474 patients were randomly assigned to receive a ventricular pacemaker and 1094 to receive a physiologic pacemaker. The annual rate of stroke or death due to cardiovascular causes was 5.5 percent with ventricular pacing, as compared with 4.9 percent with physiologic pacing (reduction in relative risk, 9.4 percent; 95 percent confidence interval, -10.5 to 25.7 percent [the negative value indicates an increase in risk]; P=0.33). The annual rate of atrial fibrillation was significantly lower among the patients in the physiologic-pacing group (5.3 percent) than among those in the ventricular-pacing group (6.6 percent), for a reduction in relative risk of 18.0 percent (95 percent confidence interval, 0.3 to 32.6 percent; P=0.05). The effect on the rate of atrial fibrillation was not apparent until two years after implantation. The observed annual rates of death from all causes and of hospitalization for heart failure were lower among the patients with a physiologic pacemaker than among those with a ventricular pacemaker, but not significantly so (annual rates of death, 6.6 percent with ventricular pacing and 6.3 percent with physiologic pacing; annual rates of hospitalization for heart failure, 3.5 percent and 3.1 percent, respectively). There were significantly more perioperative complications with physiologic pacing than with ventricular pacing (9.0 percent vs. 3.8 percent, P<0.001). CONCLUSIONS: Physiologic pacing provides little benefit over ventricular pacing for the prevention of stroke or death due to cardiovascular causes.
机译:背景:有证据表明,生理起搏(双腔或心房)可能优于单腔(心室)起搏,因为它与降低心房纤颤,中风和死亡的风险有关。这些益处尚未在大型随机对照试验中进行评估。方法:在加拿大的32个中心,计划首次植入起搏器以治疗症状性心动过缓的无慢性心房颤动的患者符合入组条件。我们随机分配患者接受心室起搏器或生理起搏器,并平均随访三年。主要结果是由于心血管原因导致的中风或死亡。次要结局是因任何原因死亡,房颤和因心力衰竭住院。结果:总共1474例患者被随机分配为接受心室起搏器,而1094例为生理起搏器。心室起搏导致的因心血管原因导致的中风或死亡的年率为5.5%,而生理起搏则为4.9%(相对风险降低9.4%;置信区间为95%,-10.5至25.7%[负值表示风险增加]; P = 0.33)。生理起搏组患者的年房颤发生率(5.3%)显着低于心室起搏组的患者(6.6%),相对危险度降低了18.0%(95%置信区间) ,则为0.3%至32.6%; P = 0.05)。直到植入后两年,对心房纤颤率的影响才明显。使用生理起搏器的患者因各种原因和因心力衰竭住院的年死亡率均低于使用心室起搏器的患者,但并非如此(年死亡率,心室起搏的年死亡率为6.6%,心室起搏的年死亡率为6.3%)。生理起搏;每年因心力衰竭住院的比率分别为3.5%和3.1%)。生理性起搏的围手术期并发症明显多于心室起搏(9.0%vs. 3.8%,P <0.001)。结论:生理起搏在预防因心血管原因引起的中风或死亡方面比起搏起搏作用小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号